Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 27 peer-reviewed journal articles Updated
Neurology · Developmental and Epileptic Encephalopathy

The Long-Term Journey: Quality of Life and Transition

At a Glance

As children with Developmental and Epileptic Encephalopathy (DEE) grow, care shifts from strict seizure control to maximizing overall quality of life. Transition planning for adult medical care should begin by age 12 to 14 to ensure continuous medical, legal, and supportive care.

Living with Developmental and Epileptic Encephalopathy (DEE) is a marathon, not a sprint. As your child grows from an infant into an adolescent and eventually an adult, the challenges—and the goals of treatment—will naturally shift [1][2]. While the early years are often focused on the “crisis” of stopping seizures, the long-term journey is about building a life characterized by comfort, connection, and joy [3][4].

Shifting the Focus: Quality of Life (QoL)

In early childhood, the priority is often “seizure freedom” at any cost. However, for many adults with genetic DEEs like SCN1A (Dravet Syndrome) or STXBP1, seizures may remain chronic and drug-resistant [5][2].

As the child matures, the definition of success often shifts toward Quality of Life:

  • Communication: Prioritizing ways for the child to express their needs and choices, even if they remain non-verbal [3].
  • Comfort and Symptom Management: Addressing the “hidden” symptoms like chronic pain, GI distress, or sleep disorders that can impact happiness more than a single seizure does [6][7].
  • Avoiding Toxicity: Balancing the benefits of anti-seizure medications against side effects like extreme lethargy or behavior issues [2][8].

The Role of Palliative and Supportive Care

A common misconception is that Palliative Care is only for the end of life. In the world of DEE, it is actually a layer of “supportive care” that can be started at any time [9][10]. Palliative teams specialize in:

  • Complex Symptom Management: Helping with difficult-to-treat pain, secretions, or agitation [6].
  • Advance Care Planning: Helping families make difficult decisions about feeding tubes, breathing support, or surgical interventions based on the family’s values [11][12].
  • Care Coordination: Improving communication between the many specialists involved in your child’s care [13][14].

The Transition to Adult Care

One of the most significant hurdles for DEE families is the move from the pediatric system to the adult medical system, which often lacks the same level of multidisciplinary support [15][16].

  • The “Cliff” Effect: Many families feel they “fall off a cliff” at age 18 or 21 when they lose their pediatric team and school-based therapies [17].
  • Early Planning: Experts recommend starting transition discussions as early as age 12 to 14 [18][19]. This includes discussing legal guardianship, adult housing options, and finding an adult neurologist who understands rare genetic epilepsies [1][20].

The Impact on the Family Unit

The “caregiver burden” in DEE is profound and affects every member of the family [21][22].

  • Parental Health: Caregivers of adults with DEE face long-term physical, financial, and emotional strain [23][24]. Accessing respite care (temporary relief for caregivers) is essential for maintaining your own health [21].
  • Siblings (The “Glass Children”): Siblings often experience a unique set of challenges, including “survivor’s guilt” or feeling overlooked because so much attention is focused on their brother or sister [21]. It is vital to ensure siblings have their own support networks and time where they are the priority.
Stage of Life Primary Focus Key Transition Milestone
Infancy/Early Childhood Seizure control and diagnosis [25]. Genetic testing and early intervention [26].
School Age Developmental progress and socialization [27]. IEP (Individualized Education Program) and therapy goals.
Adolescence Hormonal changes and seizure evolution [2]. Initiating transition planning (Guardianship, Adult Meds) [18].
Adulthood Quality of life, comfort, and community [3]. Transfer to adult specialized care [1].

Your child’s journey is unique, and your role as their advocate remains the most powerful force in ensuring they live a life full of dignity and joy [20][4].

Return to Home Page

Common questions in this guide

When should we begin transitioning a child with DEE to adult medical care?
Experts recommend starting transition discussions as early as age 12 to 14. Early planning allows time to establish legal guardianship, explore adult housing options, and find adult neurologists who specialize in rare genetic epilepsies.
What is the role of palliative care for Developmental and Epileptic Encephalopathy?
Palliative care provides supportive care that can be started at any time, not just at the end of life. These specialized teams help manage complex symptoms like pain and sleep disorders, assist with advance care planning, and coordinate communication among your medical providers.
How do treatment goals for DEE change as my child grows into adulthood?
While early childhood treatment often focuses strictly on stopping seizures, adult care frequently shifts toward maximizing overall quality of life. This includes prioritizing communication, managing hidden symptoms like gastrointestinal distress, and avoiding severe medication side effects.
What legal and financial steps are needed when a child with DEE turns 18?
Before your child reaches adulthood, it is crucial to establish legal guardianship and set up financial protections like special needs trusts. These steps ensure you can continue making medical and financial decisions for their care in the adult system.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.When should we begin the formal transition process to adult neurology, and can you recommend an adult provider who specializes in genetic DEEs?
  2. 2.How do you expect my child's seizure types and frequency to evolve as they enter adulthood?
  3. 3.Can we consult with a palliative or supportive care team to help manage my child's daily symptoms like pain, sleep, or GI discomfort?
  4. 4.What legal and financial steps, such as guardianship or special needs trusts, do we need to finalize before my child turns 18?
  5. 5.Are there adult-specific precision therapies or clinical trials available for my child's specific mutation?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (27)
  1. 1

    Organizational and behavioral models in the management of patients with developmental and epileptic encephalopathy, Lennox-Gastaut syndrome and Dravet syndrome in Italy: a focus on the transition from pediatric to adult care.

    Di Bonaventura C, Coppola A, Di Gennaro G, et al.

    Frontiers in health services 2025; (5()):1632564 doi:10.3389/frhs.2025.1632564.

    PMID: 41282975
  2. 2

    Dravet syndrome diagnosed in adults.

    Dudley AM, Peña-Ceballos J, El-Naggar H, et al.

    Practical neurology 2026; (26(2)):124-132 doi:10.1136/pn-2025-004743.

    PMID: 41136202
  3. 3

    How Encephalopathy Impacts Language Ability: A Scoping Review of the Linguistic Abilities of Adults with Developmental and Epileptic Encephalopathy.

    Papatheodorou I, Stavrakaki S, Koukoulioti V, et al.

    Medicina (Kaunas, Lithuania) 2024; (60(10)) doi:10.3390/medicina60101635.

    PMID: 39459422
  4. 4

    Caregiver-reported meaningful change in functional domains for individuals with developmental and epileptic encephalopathy: A convergent mixed-methods design.

    Downs J, Haywood S, Ludwig NN, et al.

    Developmental medicine and child neurology 2025; (67(12)):1616-1627 doi:10.1111/dmcn.16363.

    PMID: 40372822
  5. 5

    Adult-Onset Neurological Deterioration in Dravet Syndrome Associated With a Novel SCN1A Missense Variant (p.Gly1371Asp): A Case Report.

    Yokoyama K, Miyazaki S, Murayama K, et al.

    Cureus 2025; (17(9)):e93228 doi:10.7759/cureus.93228.

    PMID: 41158906
  6. 6

    A multidisciplinary quality improvement initiative to improve neonatal end-of-life care in a level IV NICU.

    Lofgren H, Lentin S, DiMatteo A, et al.

    BMC palliative care 2025; (24(1)):286 doi:10.1186/s12904-025-01899-9.

    PMID: 41225558
  7. 7

    Association between palliative care and healthcare outcomes among adults with terminal non-cancer illness: population based matched cohort study.

    Quinn KL, Stukel T, Stall NM, et al.

    BMJ (Clinical research ed.) 2020; (370()):m2257 doi:10.1136/bmj.m2257.

    PMID: 32631907
  8. 8

    Dravet Syndrome: Diagnosis and Long-Term Course.

    Connolly MB

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2016; (43 Suppl 3()):S3-8 doi:10.1017/cjn.2016.243.

    PMID: 27264139
  9. 9

    Timely integration of palliative care. the reality check. a retrospective analysis.

    Adamidis F, Baumgartner NS, Kitta A, et al.

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2024; (32(8)):518 doi:10.1007/s00520-024-08721-x.

    PMID: 39017732
  10. 10

    Haematologists and palliative care: a multicentric qualitative study.

    Tricou C, Munier S, Phan-Hoang N, et al.

    BMJ supportive & palliative care 2022; (12(e6)):e798-e802 doi:10.1136/bmjspcare-2018-001714.

    PMID: 30808629
  11. 11

    Timing and outcomes of outpatient palliative care consultations in advanced cancer.

    Torres-Tenor JL, Bruera E, Ortí-Hortelano MJ, et al.

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026; doi:10.1007/s12094-026-04276-x.

    PMID: 41758445
  12. 12

    Inappropriate end-of-life cancer care in a generalist and specialist palliative care model: a nationwide retrospective population-based observational study.

    Boddaert MS, Pereira C, Adema J, et al.

    BMJ supportive & palliative care 2022; (12(e1)):e137-e145 doi:10.1136/bmjspcare-2020-002302.

    PMID: 33355176
  13. 13

    Health system related kidney supportive care interventions for adults with chronic kidney disease: A systematic review.

    Dharmagunawardene D, Kularatna S, Halahakone U, et al.

    Journal of renal care 2025; (51(1)):e12517 doi:10.1111/jorc.12517.

    PMID: 39639604
  14. 14

    Potentially Inappropriate End of Life Care and Healthcare Costs in the Last 30 Days of Life in Regions Providing Integrated Palliative Care in the Netherlands: A Registration-based Study.

    Pereira CFR, Dijxhoorn AQ, Koekoek B, et al.

    International journal of integrated care 2024; (24(3)):6 doi:10.5334/ijic.7504.

    PMID: 39005964
  15. 15

    Patients' and Providers' Perspectives of the Transition of Care from Hospital to Community for Hispanic/Latino Adults with Diabetes.

    Padilla BI, Granados E, Corsino L

    Hispanic health care international : the official journal of the National Association of Hispanic Nurses 2025; (23(2)):85-93 doi:10.1177/15404153241269473.

    PMID: 39105422
  16. 16

    Transitioning spine care from the pediatric to adult center: Challenges and future directions.

    Shen J, Klineberg E, Yaszay B, et al.

    Health care transitions 2025; (3()):100107 doi:10.1016/j.hctj.2025.100107.

    PMID: 40599635
  17. 17

    Transitional Care Navigation.

    Rodriguez AL, Cappelletti L, Kurian SM, et al.

    Seminars in oncology nursing 2024; (40(2)):151580 doi:10.1016/j.soncn.2024.151580.

    PMID: 38290928
  18. 18

    Facilitators, barriers, and guidance to successful implementation of multidisciplinary transitional care interventions: A qualitative systematic review using the consolidated framework for implementation research.

    Collet R, van Grootel J, van der Leeden M, et al.

    International journal of nursing studies advances 2025; (8()):100269 doi:10.1016/j.ijnsa.2024.100269.

    PMID: 39691681
  19. 19

    Healthcare transition and inflammatory bowel disease: the challenges experienced by young adults after transfer from paediatric to adult health services.

    Constantinidis DD, O'Brien CL, Hebbard G, et al.

    Psychology, health & medicine 2025; 1-23 doi:10.1080/13548506.2025.2497001.

    PMID: 40301717
  20. 20

    The Impact of Perceived Self-Efficacy on Healthcare Transition Outcomes: Perceptions From Parents and Young People.

    Kwok C, Waller D, Kohn M, Doyle FL

    Child: care, health and development 2025; (51(4)):e70125 doi:10.1111/cch.70125.

    PMID: 40562061
  21. 21

    Systematic review of indirect costs to families of children with developmental epileptic encephalopathies.

    Abdelmageed S, Du RY, Carroll M, et al.

    Orphanet journal of rare diseases 2025; (20(1)):579 doi:10.1186/s13023-025-04081-9.

    PMID: 41225515
  22. 22

    Determinants of overburdening among informal carers: a systematic review.

    Lindt N, van Berkel J, Mulder BC

    BMC geriatrics 2020; (20(1)):304 doi:10.1186/s12877-020-01708-3.

    PMID: 32847493
  23. 23

    Study of caregiver stress among carers of patients of cognitive impairment: An observational study from memory clinic of AIIMS, India.

    Kumari B, Chakrawarty A, Rao AR, et al.

    Journal of family medicine and primary care 2025; (14(5)):1728-1734 doi:10.4103/jfmpc.jfmpc_1069_24.

    PMID: 40547749
  24. 24

    The association between stroke and caregiver employment after survivors' discharge: a cross-sectional analysis within a longitudinal study.

    Petrosino F, Bartoli D, Iovino P, et al.

    European journal of cardiovascular nursing 2025; (24(7)):1067-1074 doi:10.1093/eurjcn/zvaf080.

    PMID: 40304449
  25. 25

    Targeted gene panel sequencing in early infantile onset developmental and epileptic encephalopathy.

    Na JH, Shin S, Yang D, et al.

    Brain & development 2020; (42(6)):438-448 doi:10.1016/j.braindev.2020.02.004.

    PMID: 32139178
  26. 26

    Genetic evaluation of children with autism spectrum disorders in developing and low-resource areas.

    Masri AT, Nasir A, Irshaid F, et al.

    Autism : the international journal of research and practice 2022; (26(6)):1491-1498 doi:10.1177/13623613211055535.

    PMID: 34781785
  27. 27

    Early onset developmental and epileptic encephalopathy and Rett-like phenotype in a 15-year-old girl affected by Cornelia de Lange syndrome type 2 due to a SMC1A gene mutation.

    Parmeggiani L, Stanzial F, Menna E, et al.

    Epilepsy & behavior reports 2023; (24()):100634 doi:10.1016/j.ebr.2023.100634.

    PMID: 38076278

This page provides educational information on long-term care and transition planning for genetic DEE. It is not a substitute for professional medical advice or legal counsel regarding guardianship and care arrangements.

Get notified when new evidence is published on Genetic developmental and epileptic encephalopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.